Full Text View
Tabular View
No Study Results Posted
Related Studies
Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
This study is ongoing, but not recruiting participants.
Study NCT01565668   Information provided by Ambit Biosciences Corporation

First Received on March 27, 2012.   Last Updated on September 19, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial